Exchange Traded Concepts’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $945K | Sell |
|
|||||
|
2025
Q2 | $915K | Sell |
|
|||||
|
2025
Q1 | $1M | Sell |
|
|||||
|
2024
Q4 | $902K | Buy |
|
|||||
|
2024
Q3 | $981K | Buy |
|
|||||
|
2024
Q2 | $834K | Sell |
|
|||||
|
2024
Q1 | $566K | Sell |
|
|||||
|
2023
Q4 | $1.04M | Buy |
|
|||||
|
2023
Q3 | $597K | Sell |
|
|||||
|
2023
Q2 | $1.56M | Sell |
|
|||||
|
2023
Q1 | $4.26M | Buy |
|
|||||
|
2022
Q4 | $1.75M | Sell |
|
|||||
|
2022
Q3 | $1.62M | Sell |
|
|||||
|
2022
Q2 | $1.93M | Sell |
|
|||||
|
2022
Q1 | $2.21M | Buy |
|
|||||
|
2021
Q4 | $1.51M | Sell |
|
|||||
|
2021
Q3 | $1.72M | Sell |
|
|||||
|
2021
Q2 | $1.88M | Buy |
|
|||||
|
2021
Q1 | $1.52M | Buy |
|
|||||
|
2020
Q4 | $959K | Buy |
|
|||||
|
2020
Q3 | $400K | Buy |
|
|||||
|
2020
Q2 | $218K | Buy |
|
|||||
|
2020
Q1 | $77K | Buy |
|
|||||
|
2019
Q4 | $44K | Buy |
|